HPS Pharmacies wish to advise that Sandoz Australia, in consultation with the Therapeutic Goods Administration (TGA), have given notice of a drug recall for Curam® Duo 400/57 as follows:
Curam Duo® Powder for Suspension
Amoxicillin + Clavulanic Acid 400mg+57mg/5mL
The only batches affected by this recall are JC5418 and JC5419. Both affected batches have an expiry date of July 2021.
This drug recall has been initiated following identification of an anomaly during the manufacturing process that may affect the air-tight sealing system. Failure of the seal may allow entry of moisture into the product from the atmosphere. This may cause degradation of the active ingredients and reduce effectiveness.
Please inspect your stock and quarantine all affected products. If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All affected products will be quarantined for return to the supplier and HPS Pharmacies will arrange for replacement stock as soon as possible. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Sandoz on 1800 726 369.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates